LncRNA AC012360.1 facilitates growth and metastasis by regulating the miR‐139‐5p/LPCAT1 axis in hepatocellular carcinoma

Long noncoding RNAs (lncRNAs) participate in tumorigenesis and tumor progression. However, whether lncRNA AC012360.1 contributes to hepatocellular carcinoma (HCC) is unknown. In HCC tissues, differentially expressed lncRNAs were identified by bioinformatics. AC012360.1 level was validated and its role in HCC progression was investigated. Among the top 10 upregulated lncRNAs, AC012360.1 exhibited the greatest increase in HCC tissues. Additionally, AC012360.1 was upregulated in HCC tissues/cells. Moreover, AC012360.1 knockdown refrained cell proliferation/metastasis and tumor growth. Conversely, AC012360.1 overexpression showed an oncogenic role. AC012360.1 and lysophosphatidylcholine acyltransferase 1 (LPCAT1) contained miR-139-5p binding sites. Furthermore, miR-139-5p silencing partially mitigated the role of AC012360.1 knockdown, while LPCAT1 knockdown partially abolished the tumor-promoting effect of AC012360.1 overexpression. In conclusion, AC012360.1 exhibited its oncogenic function in HCC through sponging miR-139-5p and upregulating LPCAT1 expression.

[1]  Jinlong Chen,et al.  LPCAT1 functions as an oncogene in cervical cancer through mediating JAK2/STAT3 signaling. , 2022, Experimental cell research.

[2]  M. Hashemi,et al.  Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy. , 2022, Pharmacological research.

[3]  Ji-wen He,et al.  LncRNA CRNDE is involved in radiation resistance in hepatocellular carcinoma via modulating the SP1/PDK1 axis. , 2022, Neoplasma.

[4]  Xudong Liu,et al.  ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma , 2022, Journal of immunology research.

[5]  Xiaohong Ma,et al.  Overexpression of LPCAT1 enhances endometrial cancer stemness and metastasis by changing lipid components and activating TGF-β/Smad2/3 signaling pathway , 2022, Acta biochimica et biophysica Sinica.

[6]  Hui Li,et al.  Circular RNA circZCCHC6 contributes to tumorigenesis by regulating LPCAT1 via miR-433-3p in non-small cell lung cancer , 2022, Clinical and Experimental Medicine.

[7]  Xing Sun,et al.  Lysophosphatidylcholine acyltransferase 1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway. , 2022, Annals of hepatology.

[8]  Hong Yang,et al.  LPCAT1 overexpression promotes the progression of hepatocellular carcinoma , 2021, Cancer Cell International.

[9]  Yuqian Wang,et al.  LPCAT1 promotes cutaneous squamous cell carcinoma via EGFR-mediated AKT/p38MAPK signaling pathways. , 2021, The Journal of investigative dermatology.

[10]  Q. Zhang,et al.  LpCat1 Promotes Malignant Transformation of Hepatocellular Carcinoma Cells by Directly Suppressing STAT1 , 2021, Frontiers in Oncology.

[11]  Bixiang Zhang,et al.  Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma , 2021, Aging.

[12]  Yan Liu,et al.  Mir-139-5p inhibits glioma cell proliferation and progression by targeting GABRA1 , 2021, Journal of translational medicine.

[13]  Xiangyuan Jin,et al.  MiR-139-5p Targetedly Regulates YAF2 and Mediates the AKT/P38 MAPK Signaling Pathway to Alleviate the Metastasis of Non-Small Cell Lung Cancer Cells and Their Resistance Against Cisplatin , 2021, Cancer management and research.

[14]  R. Fietkau,et al.  Identification of 15 lncRNAs Signature for Predicting Survival Benefit of Advanced Melanoma Patients Treated with Anti-PD-1 Monotherapy , 2021, Cells.

[15]  Liang Zhou,et al.  LncRNA BACE1-AS enhances the invasive and metastatic capacity of hepatocellular carcinoma cells through mediating miR-377-3p/CELF1 axis. , 2021, Life sciences.

[16]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[17]  Xing-Xing He,et al.  LncRNA NBR2 inhibits tumorigenesis by regulating autophagy in hepatocellular carcinoma. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  Yue Zhao,et al.  Long non-coding RNA HOXA-AS3 promotes cell proliferation of oral squamous cell carcinoma through sponging microRNA miR-218-5p , 2021, Bioengineered.

[19]  Chunying Liu,et al.  miR-139-5p enhances cisplatin sensitivity in non-small cell lung cancer cells by inhibiting cell proliferation and promoting apoptosis via the targeting of Homeobox protein Hox-B2 , 2020, Molecular medicine reports.

[20]  Minglun Li,et al.  LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production , 2020, PloS one.

[21]  R. Xu,et al.  LncRNA‐mediated posttranslational modifications and reprogramming of energy metabolism in cancer , 2020, Cancer communications.

[22]  S. Cui,et al.  Low expression of lncRNA MGC27345 is associated with poor prognosis in gastric cancer patients. , 2020, European review for medical and pharmacological sciences.

[23]  Jian Zhang,et al.  LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma , 2020, Genes & Diseases.

[24]  B. Baradaran,et al.  Diagnostic, prognostic, and therapeutic significance of miR-139-5p in cancers. , 2020, Life sciences.

[25]  A. Yang,et al.  A miR-205-LPCAT1 axis contributes to proliferation and progression in multiple cancers. , 2020, Biochemical and biophysical research communications.

[26]  Weifeng He,et al.  The role of long noncoding RNAs in hepatocellular carcinoma , 2020, Molecular Cancer.

[27]  M. Chai,et al.  Progress and prospects of biomarkers in primary liver cancer (Review). , 2020, International journal of oncology.

[28]  Mihye Lee,et al.  Regulatory Mechanism of MicroRNA Expression in Cancer , 2020, International journal of molecular sciences.

[29]  Wenyu Lin,et al.  LncRNAs regulate metabolism in cancer , 2020, International journal of biological sciences.

[30]  Rong Li,et al.  LncRNA PTENP1 inhibits cervical cancer progression by suppressing miR-106b , 2020, Artificial cells, nanomedicine, and biotechnology.

[31]  Hao Wu,et al.  Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcoma. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[32]  S. Talluri,et al.  HOTAIR LncRNA: A novel oncogenic propellant in human cancer. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[33]  T. Padilla-Benavides,et al.  Extracellular-Signal Regulated Kinase: A Central Molecule Driving Epithelial–Mesenchymal Transition in Cancer , 2019, International journal of molecular sciences.

[34]  Gang Wu,et al.  LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway , 2019, Journal of experimental & clinical cancer research : CR.

[35]  P. Tontonoz,et al.  Phospholipid Remodeling in Physiology and Disease. , 2019, Annual review of physiology.

[36]  P. Li,et al.  MiR‐139‐5p, miR‐940 and miR‐193a‐5p inhibit the growth of hepatocellular carcinoma by targeting SPOCK1 , 2019, Journal of cellular and molecular medicine.

[37]  Jinhui Liu,et al.  Tumor-suppressor role of miR-139-5p in endometrial cancer , 2018, Cancer Cell International.

[38]  Qinkang Lu,et al.  Molecular screening of the LPCAT1 gene in patients with retinitis pigmentosa without defined mutations in known retinitis pigmentosa genes. , 2015, Molecular medicine reports.

[39]  Yuan Yin,et al.  MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1 , 2014, Protein & Cell.

[40]  J. Zucman‐Rossi,et al.  Hepatocellular carcinoma , 1998, Nature Reviews Disease Primers.

[41]  Matthew S. Johnson,et al.  The diagnosis and treatment of hepatocellular carcinoma. , 1998, Seminars in diagnostic pathology.

[42]  OUP accepted manuscript , 2021, Nucleic Acids Research.

[43]  Wenyu Zhang,et al.  Downregulation of miR-139-5p promotes prostate cancer progression through regulation of SOX5. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[44]  Lichun Wang,et al.  Reconstruction and Analysis of the Differentially Expressed IncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA in Hepatocellular Carcinoma. , 2019, Critical reviews in eukaryotic gene expression.